3 Patents
- US122153872025Biomarker Predictive of Responsiveness to Alpha 7 Nicotinic Acetylcholine Receptor Activator Treatment
Novartis AG
0 cites - US122016122025Use of Mavoglurant in the Reduction of Alcohol Use or in Preventing Relapse Into Alcohol Use
NOVARTIS AG
0 cites - US118780012024Use of Mavoglurant in the Reduction of Cocaine Use or in Preventing Relapse Into Cocaine Use
NOVARTIS AG
0 cites